CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 90 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $566,947,000 | -23.5% | 4,788 | -23.7% | 0.00% | – |
| Q4 2020 | $741,495,000 | +6.3% | 6,278 | 0.0% | 0.00% | – |
| Q3 2020 | $697,737,000 | +91.3% | 6,278 | +75.9% | 0.00% | – |
| Q2 2020 | $364,783,000 | -5.3% | 3,570 | 0.0% | 0.00% | – |
| Q1 2020 | $385,310,000 | -7.3% | 3,570 | 0.0% | 0.00% | – |
| Q4 2019 | $415,477,000 | -58.9% | 3,570 | -59.6% | 0.00% | -100.0% |
| Q3 2019 | $1,012,029,000 | +169.6% | 8,841 | +124.4% | 0.00% | – |
| Q2 2019 | $375,387,000 | -87.6% | 3,939 | -88.2% | 0.00% | -100.0% |
| Q1 2019 | $3,035,888,000 | -81.0% | 33,270 | -84.2% | 0.00% | -85.7% |
| Q4 2018 | $15,996,059,000 | -2.7% | 210,724 | +2.6% | 0.01% | +16.7% |
| Q3 2018 | $16,433,920,000 | – | 205,424 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 137,557 | $11,142,000 | 6.62% |
| COMGEST GLOBAL INVESTORS S.A.S. | 637,752 | $51,658,000 | 1.13% |
| Black Creek Investment Management Inc. | 411,525 | $33,334,000 | 1.09% |
| Hillhouse Capital Management | 618,391 | $50,090,000 | 0.88% |
| RUDMAN ERROL M | 21,301 | $1,725,000 | 0.83% |
| JUPITER ASSET MANAGEMENT LTD | 263,705 | $21,360,000 | 0.65% |
| York Capital Management Global Advisors, LLC | 341,616 | $27,671,000 | 0.62% |
| VONTOBEL ASSET MANAGEMENT INC | 873,968 | $71,525,000 | 0.51% |
| Temasek Holdings (Private) Ltd | 990,000 | $80,190,000 | 0.44% |
| WASATCH ADVISORS LP | 292,216 | $23,669,000 | 0.31% |